The first ASCO Annual Meeting that I attended was in 1982, soon after I completed my fellowship in gynecologic oncology. That meeting seemed substantial and vast, but in retrospect, I recognize how small it was compared to the current venue. Still, it was an inspiring experience that stimulated and encouraged my continuous participation in our extraordinary Society.

Since becoming a member 33 years ago, I have progressively increased my involvement with our organization and at our Annual Meetings beyond attendance. I have had the pleasure of making oral and poster presentations, discussing papers, participating on several ASCO committees, and of course, editing this publication. Most valuable to me are the collegial relationships I have developed with many talented individuals who have influenced my career and nurtured my understanding of oncology.

Now, as I head to Chicago each year for the Annual Meeting, I tell my colleagues that I am going to meet with 30,000 of my friends!

This year’s Annual Meeting also promises to be an inspiring event, with scientific presentations that will deepen our current understanding of cancer care and strengthen our commitment to our patients and our global oncology community.

One of the challenges we must consider for our patients is how to optimally integrate palliative/hospice care and anticancer therapy. Drs. Daniel W. Bowles, D. Ross Camidge, and Jeanie M. Youngwerth review the issue and consider examples from the United Kingdom and the U.S. Veterans Health Administration.

In this issue we continue our “Ace Your Interview” series, with practical advice for young professionals trying to secure their first job in oncology. The valuable tips shared by Dean Walker will help you skillfully answer some of the tough questions you can expect to be asked at an interview in a community practice.

This month, we take time to honor Dr. Allen S. Lichter, who is retiring in June after 10 years as CEO of ASCO and the Conquer Cancer Foundation. Under his leadership, our Society has grown and flourished, and we at ASCO Connection thank him for his incredible service.

It is a privilege to be personally engaged in the meaningful activities of our Society. Together, we have generated a positive impact on the development of oncology practice throughout the world, and can feel justifiable pride in our shared and sustained contributions.

Thank you for reading, and I hope to see you in Chicago in June!